News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

PerkinElmer, Inc. (PKI) Establishes ViaCord Research Institute™ to Further Cord Blood Stem Cell Advancements


7/3/2008 8:43:29 AM

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc., a global leader in Health Sciences and Photonics, today announced the creation of the ViaCord Research Institute™ (VRI™) aimed at investigating new potential future uses of umbilical cord blood-derived stem cells. Led by a team of leading scientists and physicians, VRI will focus on supporting science, technology and medical treatments using cord blood stem cells in five key areas: cord blood technologies, emerging stem cell therapies, genetic screening, product development and related transplants.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES